Biocryst Pharmaceuticals, Inc. Patent applications |
Patent application number | Title | Published |
20140178372 | METHODS OF TREATING HEMATOLOGIC CANCERS - The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits. | 06-26-2014 |
20130331404 | Methods and Compositions for Inhibition of Polymerase - The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects. The methods comprise administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, or a composition comprising a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier. The composition or method may optionally comprise one or more additional anti-viral agents. | 12-12-2013 |
20130071415 | Heterocyclic Compounds as Janus Kinase Inhibitors - The invention provides compounds of formula I: | 03-21-2013 |
20120312126 | Metal Recovery Method and Dialysis Device - Provided is a valuable-metal recovery method for recovering metals from lithium ion batteries using comparatively simple equipment and without using a cumbersome process. In said method, a positive electrode material from lithium ion batteries, containing lithium and a transition metal, is dissolved in an acidic solution, thereby generating lithium ions and ions of the transition metal in the acidic solution. Said acidic solution and a recovery liquid are then made to flow with an anion-permeable membrane interposed therebetween, causing the lithium ions to permeate from the acidic solution to recovery solution. Lithium ions are then recovered from the recovery liquid containing dissolved lithium ions. | 12-13-2012 |
20120213735 | THERAPEUTIC FUROPYRIMIDINES AND THIENOPYRIMIDINES - The invention provides compounds of formula I, II, and III as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula I, II, and III are useful as anti-viral agents and/or as anti-cancer agents. | 08-23-2012 |
20120149691 | Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors - The invention provides compounds of formula I: | 06-14-2012 |
20120149662 | Heterocyclic Compounds as Janus Kinase Inhibitors - The invention provides compounds of formula (I): | 06-14-2012 |
20120142617 | ANTIVIRAL THERAPEUTIC AGENTS - The invention provides compounds of Formula I: | 06-07-2012 |
20120059057 | ANTIVIRAL TREATMENTS - The invention provides unit dosage forms, kits, and methods useful for treating viral infections. | 03-08-2012 |
20110165183 | PIPERIDINE DERIVATIVES AS JAK3 INHIBITORS - The invention provides a compound of formula (I): wherein W is a bicyclic heteroaromatic group; or a salt thereof. The compounds and salts thereof have beneficial therapeutic properties (e.g. immunosuppressant properties). | 07-07-2011 |
20110144321 | SYNTHETIC INTERMEDIATES AND PROCESSES - The invention provides novel synthetic intermediates and processes that can be used to prepare compounds of formula (I), wherein R | 06-16-2011 |
20110038858 | METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS - The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits. | 02-17-2011 |
20110015264 | INTRAMUSCULAR ANTIVIRAL TREATMENTS - The invention provides unit dosage forms, kits, and methods useful for treating viral infections. | 01-20-2011 |
20110002886 | TETRAHYDROFURO [3,4-D] DIOXOLANE COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS AND CANCER - The invention provides compounds of formula (I), as described herein, or pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula (I) are useful as anti-viral agents and/or as anti-cancer agents. | 01-06-2011 |
20090247750 | PROCESS FOR PREPARING NUCLEOSIDE ANALOGS - The invention provides an improved method for preparing a compound of formula 2: | 10-01-2009 |
20080300200 | Therapeutic Furopyrimidines and Thienopyrimidines - The invention provides compounds of formula I, II, and III as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula I, II, and III are useful as anti-viral agents and/or as anti-cancer agents. | 12-04-2008 |